Used in pharmaceutical research as a key intermediate in the synthesis of bioactive molecules. Its unique structure, featuring a difluoroazetidine ring, enhances the metabolic stability and potency of drug candidates. Commonly applied in the development of enzyme inhibitors and receptor modulators, particularly in the fields of oncology and central nervous system disorders. Also employed in medicinal chemistry to improve the pharmacokinetic properties of lead compounds.